# Quality of Life Validation in Laryngitis

> **NCT00641264** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 90 (estimated)

## Conditions studied

- Laryngopharyngeal Reflux (LPR)

## Interventions

- **DRUG:** Omeprazole
- **BEHAVIORAL:** Quality of Life questionnaire

## Key facts

- **NCT ID:** NCT00641264
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** 2003-06
- **Final completion:** 2003-06
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2009-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00641264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00641264, "Quality of Life Validation in Laryngitis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00641264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*